发明名称 |
HEMOSTATIC PHARMACEUTICAL COMPOSITION |
摘要 |
[Problem] The present invention addresses the problem of providing a hemostatic pharmaceutical composition which has higher usability compared with conventional hemostatic agents each utilizing a biogel, and which can be formed into a transparent and homogeneous hydrogel in a broad pH range. [Solution] A hemostatic pharmaceutical composition containing a (sugar chain)-polypeptide complex is provided, said hemostatic pharmaceutical composition being characterized in that the polypeptide in the (sugar chain)-polypeptide complex is a polypeptide comprising an amino acid sequence in which a polar amino acid residue and a non-polar amino acid residue are arranged alternately, wherein one or multiple sugar chains are bound to the polypeptide. |
申请公布号 |
SG11201607893T(A) |
申请公布日期 |
2016.11.29 |
申请号 |
SGT11201607893 |
申请日期 |
2014.08.06 |
申请人 |
OTSUKA CHEMICAL CO., LTD. |
发明人 |
SAIJO, HAYATO;OCHIAI, HIROFUMI;SHIMODA, TAIJI |
分类号 |
A61L31/00;C07K9/00 |
主分类号 |
A61L31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|